Investing Profile

Robert Garland

VCInvestor

Venture Partner at New Enterprise Associates (NEA)

nea.comSan Francisco, California
Photo of Robert Garland, Venture Partner at New Enterprise Associates (NEA)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$50K - $50.0M
$25.0M
10
$5B
CompanyStageDateRound SizeTotal Raised
Cleave Therapeutics
Series BAug 2016$26M
Series AApr 2013$10M
$90M
Co-investors: Carol Gallagher (New Enterprise Associates (NEA)), Larry Lasky (The Column Group), Andrew Schwab (5am Ventures), Peter Thompson (OrbiMed), Marc Singer (Osage University Partners), Kush Parmar (5am Ventures), Alfred Scheidegger (Nextech Invest)
Sagimet Biosciences
Series DDec 2014$29M
Series CJun 2013$20M
Venture RoundOct 2012$8.1M
Venture RoundJan 2012$20M
Series BJul 2009$30M
$190M
Co-investors: Matthew McAviney (New Enterprise Associates (NEA)), David Mott (Mott Family Capital), Beth Seidenberg (Kleiner Perkins)
Trevena
Series BJul 2010$35M
Series AMar 2008$24M
$59M
Co-investors: Terry McGuire (Polaris Partners), Farah Champsi (InterWest)
Cardioxyl Pharmaceuticals
Series ADec 2006$15M
$58M
Co-investors: Bill Harrington (Osage University Partners), James Barrett